0Genotoxic Stress, Atherosclerosis, and Metabolic Syndrome- Aim 3.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Chloroquine (Primary)
- Indications Metabolic syndrome
- Focus Registrational; Therapeutic Use
- Acronyms ARCH-MS
- 25 Jun 2021 Biomarkers information updated
- 12 Jun 2013 Planned end date changed from 1 Dec 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 20 Dec 2012 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.